Patents by Inventor Sanjay Jagdish DESAI

Sanjay Jagdish DESAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparation of isoxazoline substituted benzamide compound
    Patent number: 12065414
    Abstract: The invention relates to process for the preparation of isoxazoline-substituted benzamide compound and intermediates thereof. The invention also relates to process for the preparation of Fluralaner and intermediates thereof.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: August 20, 2024
    Assignee: ZYDUS LIFESCIENCES LIMITED
    Inventors: Kumar Kamlesh Singh, Sanjay Jagdish Desai, Kuldeep Natwarlal Jain, Jitesh Amratlal Desai, Sarvil Dhirajbhai Patel
  • PROCESS FOR PREPARATION OF MIDODRINE AND INTERMEDIATES THEREOF
    Publication number: 20220144754
    Abstract: The invention relates to process for the preparation of midodrine or pharmaceutically acceptable salts thereof. The invention also relates to process for the preparation of intermediates of midodrine.
    Type: Application
    Filed: November 10, 2021
    Publication date: May 12, 2022
    Inventors: Kumar Kamlesh Singh, Sanjay Jagdish Desai, Tadikonda Pratap V., Mahesh Laljibhai Rupapara
  • PROCESS FOR PREPARATION OF ISOXAZOLINE SUBSTITUTED BENZAMIDE COMPOUND
    Publication number: 20220064130
    Abstract: The invention relates to process for the preparation of isoxazoline-substituted benzamide compound and intermediates thereof. The invention also relates to process for the preparation of Fluralaner and intermediates thereof.
    Type: Application
    Filed: September 2, 2021
    Publication date: March 3, 2022
    Inventors: Kumar Kamlesh SINGH, Sanjay Jagdish DESAI, Kuldeep Natwarlal JAIN, Jitesh Amratlal DESAI, Sarvil Dhirajbhai PATEL
  • COMPOSITION COMPRISING HIGH PURITY PYRROLE DERIVATIVE AND METHOD FOR PREPARATION THEREOF
    Publication number: 20220023262
    Abstract: The present invention relates to a composition comprising high purity pyrrole derivative and method for preparation thereof. The present invention particularly relates to compositions comprising Saroglitazar magnesium having purity of 99.0% or more, and one or more of an aldehyde compound of Formula (II), diketo oxirane compound of Formula (III), hydroxy methyl compound of Formula (IV) or dimer compound of Formula (V), relative to saroglitazar magnesium, each present in an amount of about 0.15% or less, respectively, by weight, when measured by area percentage of HPLC.
    Type: Application
    Filed: July 23, 2021
    Publication date: January 27, 2022
    Inventors: Kumar Kamlesh SINGH, Sanjay Jagdish DESAI, Piyush Rajendra SHARMA, Daya Ram PAL, Sanjeev Kumar TRIPATHI, Mayur Ramnikbhai PATEL
  • PROCESS FOR PREPARATION OF FOSNETUPITANT
    Publication number: 20210214306
    Abstract: The present invention relates to a process for the preparation of fosnetupitant. The invention further relates to an amorphous fosnetupitant chloride hydrochloride and process for the preparation thereof.
    Type: Application
    Filed: January 13, 2021
    Publication date: July 15, 2021
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Kumar Kamlesh SINGH, Sanjay Jagdish DESAI, Jagdish Maganbhai PATEL, Chirag Jayantilal VYAS, Dhaval Jashwantlal SOLANKI, Sudhir Ganpatbhai DHANANI
  • AMORPHOUS ERTUGLIFLOZIN AND PROCESS FOR ITS PREPARATION
    Publication number: 20200376017
    Abstract: An amorphous form of ertugliflozin and process for its preparation is described. A solid form of ertugliflozin and process for preparation thereof is also described.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 3, 2020
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sanjay Jagdish DESAI, Tadikonda PRATAP V., Mahesh Laljibhai RUPAPARA, Kumar Kamlesh SINGH, Hardik Bhikhubhai GHODASARA
  • Processes for the preparation of filgotinib
    Patent number: 10815227
    Abstract: The present invention relates to processes for the preparation of Filgotinib. The present invention relates to novel processes for the preparation of filgotinib. The present invention also relates to novel intermediates for the preparation of filgotinib.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: October 27, 2020
    Assignee: CADILA HEALTHCARE LIMITED
    Inventors: Sanjay Jagdish Desai, Kuldeep Natwarlal Jain, Naitik Bharatbhai Patel, Hemant Kumar Singh
  • PROCESSES FOR THE PREPARATION OF FILGOTINIB
    Publication number: 20200062744
    Abstract: The present invention relates to processes for the preparation of Filgotinib. The present invention relates to novel processes for the preparation of filgotinib. The present invention also relates to novel intermediates for the preparation of filgotinib.
    Type: Application
    Filed: August 23, 2019
    Publication date: February 27, 2020
    Inventors: Sanjay Jagdish DESAI, Kuldeep Natwarlal JAIN, Naitik Bharatbhai PATEL, Hemant Kumar SINGH
  • AMORPHOUS SOLID DISPERSION OF VALBENAZINE TOSYLATE AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20190365738
    Abstract: There is disclosed an amorphous solid dispersion of valbenazine tosylate, and a process for preparation.
    Type: Application
    Filed: May 16, 2019
    Publication date: December 5, 2019
    Inventors: Sanjay Jagdish DESAI, Kuldeep Natwarlal JAIN, Jitesh Amratlal DESAI, Akshay Dineshchandra DESAI
  • Pyrrole compound, compositions and process for preparation thereof
    Patent number: 10385017
    Abstract: The present invention relates to compositions comprising saroglitazar magnesium wherein the saroglitazar magnesium has a purity of greater than or equal to 99% by weight, and dimer compound of Formula (IV) present in an amount relative to saroglitazar magnesium less than about 0.3% by weight by area percentage of HPLC. The present invention also related to the process for the preparation thereof and pharmaceutical compositions comprising the same.
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: August 20, 2019
    Assignee: Cadila Healthcare Limited
    Inventors: Sanjay Jagdish Desai, Ramesh Chandra Singh, Daya Ram Pal, Dharmendra Arvindbhai Darji
  • Process for the preparation of brexpiprazole and intermediates thereof
    Patent number: 10358440
    Abstract: The present invention relates to Brexpiprazole having a purity of about 99.5% or more by area percentage of HPLC, having total impurities not more than 0.5% relative to brexpiprazole as measured by area percentage of HPLC, and having less than 0.1% 1-(benzo[b]thiophen-4-yl)piperazine or a salt thereof relative to brexpiprazole by area percentage of HPLC. The present invention also provides a composition comprising brexpiprazole having 1-(benzo[b]thiophen-4-yl)-piperazine or a salt thereof in an amount less than about 0.1% relative to brexpiprazole by area percentage of HPLC and process for the preparation of brexpiprazole.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: July 23, 2019
    Assignee: Cadila Healthcare Limited
    Inventors: Sanjay Jagdish Desai, Jayprakash Ajitsingh Parihar, Alpesh Pravinchandra Shah
  • PROCESSES FOR PREPARATION OF EMPAGLIFLOZIN
    Publication number: 20190202814
    Abstract: The present invention relates to processes for the preparation of empagliflozin. In particular, the present invention relates to the preparation of empagliflozin and intermediates thereof. The present invention also relates to co-crystal of empagliflozin and amino acid and amorphous form of empagliflozin.
    Type: Application
    Filed: March 7, 2019
    Publication date: July 4, 2019
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sanjay Jagdish DESAI, Jayprakash Ajitsingh PARIHAR, Mahesh Laljibhai RUPAPARA, Pranav Jitendra GANGWAR, Hardik Bhikhubhai GHODASARA
  • PROCESS FOR THE PREPARATION OF BREXPIPRAZOLE AND INTERMEDIATES THEREOF
    Publication number: 20190177309
    Abstract: The present invention relates to Brexpiprazole having a purity of about 99.5% or more by area percentage of HPLC, having total impurities not more than 0.5% relative to brexpiprazole as measured by area percentage of HPLC, and having less than 0.1% 1-(benzo[b]thiophen-4-yl)piperazine or a salt thereof relative to brexpiprazole by area percentage of HPLC. The present invention also provides a composition comprising brexpiprazole having 1-(benzo[b]thiophen-4-yl)-piperazine or a salt thereof in an amount less than about 0.1% relative to brexpiprazole by area percentage of HPLC and process for the preparation of brexpiprazole.
    Type: Application
    Filed: February 13, 2019
    Publication date: June 13, 2019
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sanjay Jagdish DESAI, Jayprakash Ajitsingh PARIHAR, Alpesh Pravinchandra SHAH
  • PYRROLE COMPOUND, COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20180265466
    Abstract: The present invention relates to compositions comprising saroglitazar magnesium wherein the saroglitazar magnesium has a purity of greater than or equal to 99% by weight, and dimer compound of Formula (IV) present in an amount relative to saroglitazar magnesium less than about 0.3% by weight by area percentage of HPLC. The present invention also related to the process for the preparation thereof and pharmaceutical compositions comprising the same.
    Type: Application
    Filed: October 13, 2016
    Publication date: September 20, 2018
    Applicant: Cadila Healthcare Ltd.
    Inventors: Sanjay Jagdish Desai, Ramesh Chandra Singh, Daya Ram Pal, Dharmendra Arvindbhai Darji
  • Process for the preparation of dapagliflozin
    Patent number: 9845303
    Abstract: Dapagliflozin compounds and process for dapagliflozin preparation are described. Pharmaceutical compositions comprising dapagliflozin or solvates of dapagliflozin, for the treatment of diabetes are also described.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: December 19, 2017
    Assignee: Cadila Healthcare Limited
    Inventors: Sanjay Jagdish Desai, Jayprakash Ajitsingh Parihar, Mahesh Laljibhai Rupapara
  • PROCESS FOR THE PREPARATION OF BREXPIPRAZOLE AND INTERMEDIATES THEREOF
    Publication number: 20170320862
    Abstract: The present invention relates to Brexpiprazole having a purity of about 99.5% or more by area percentage of HPLC, having total impurities not more than 0.5% relative to brexpiprazole as measured by area percentage of HPLC, and having less than 0.1% 1-(benzo[b]thiophen-4-yl)piperazine or a salt thereof relative to brexpiprazole by area percentage of HPLC. The present invention also provides a composition comprising brexpiprazole having 1-(benzo[b]thiophen-4-yl)-piperazine or a salt thereof in an amount less than about 0.1% relative to brexpiprazole by area percentage of HPLC and process for the preparation of brexpiprazole.
    Type: Application
    Filed: May 3, 2017
    Publication date: November 9, 2017
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sanjay Jagdish DESAI, Jayprakash Ajitsingh PARIHAR, Alpesh Pravinchandra SHAH
  • AMORPHOUS FORM OF DACLATASVIR AND ITS SALTS AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20170281599
    Abstract: This relates to an amorphous form of daclatasvir and its salts and process for preparation thereof. In particular, it relates to an amorphous form of daclatasvir and daclatasvir dihydrochloride. It also relates to pharmaceutical compositions comprising an amorphous form of daclatasvir or daclatasvir dihydrochloride for oral administration for treatment of Hepatitis C virus (HCV).
    Type: Application
    Filed: March 28, 2017
    Publication date: October 5, 2017
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sanjay Jagdish DESAI, Sandipan Prabhurao BONDGE, Naitik Bharatbhai PATEL, Chirag Vasantbhai PATEL, Sandip Kiritkumar UPADHYAY
  • PROCESSES FOR THE PREPARATION OF EMPAGLIFLOZIN
    Publication number: 20170247356
    Abstract: The present invention relates to processes for the preparation of empagliflozin. In particular, the present invention relates to the preparation of empagliflozin and intermediates thereof. The present invention also relates to co-crystal of empagliflozin and amino acid and amorphous form of empagliflozin.
    Type: Application
    Filed: August 29, 2016
    Publication date: August 31, 2017
    Inventors: Sanjay Jagdish DESAI, Jayprakash Ajitsingh PARIHAR, Mahesh Laljibhai RUPAPARA, Pranav Jitendra GANGWAR, Hardik Bhikhubhai GHODASARA
  • PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN
    Publication number: 20170166547
    Abstract: Dapagliflozin compounds and process for dapagliflozin preparation are described. Pharmaceutical compositions comprising dapagliflozin or solvates of dapagliflozin, for the treatment of diabetes are also described.
    Type: Application
    Filed: October 19, 2016
    Publication date: June 15, 2017
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sanjay Jagdish DESAI, Jayprakash Ajitsingh PARIHAR, Mahesh Laljibhai RUPAPARA
  • Process for the preparation of fulvestrant
    Patent number: 9315540
    Abstract: The present invention relates to an improved process for the preparation of Fulvestrant (I). Also, provided is novel intermediate of Fulvestrant and a process for the preparation of the same.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: April 19, 2016
    Assignee: INTAS PHARMACEUTICALS LTD.
    Inventors: Mettilda Lourdusamy, Ioan Iosif Radu, Brijesh Dinkarrai Desai, Pramod Bhagvanjibhai Pansuriya, Sanjay Jagdish Desai